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General Methods:
Chemicals and reagents were used without further purification unless otherwise noted. If
necessary, reactions were performed under argon atmosphere using anhydrous solvents. Thin
layer chromatography was performed using E. Merck silica gel 60 F254 precoated plates and
visualized using cerium ammonium molybdate stain. Flash column chromatography was carried
out with Silica Gel 60 (230-400 mesh). NMR spectra were obtained on a Varian Mercury 300
instrument. High resolution mass spectra were obtained with a Jeol JMS-600H spectrometer. The
peptide TAPTS(O-GlcNAc)TIAPG was synthesized at the Beckman Institute Biopolymer
Synthesis Center using standard Fmoc chemistry. The Fmoc-protected, peracetylated O-GlcNAc
serine amino acid was kindly synthesized by S. Tully as reported by Seitz et al.1 Baculovirus
preparation and protein expression of CREB in Spodoptera frugiperda (Sf9) cells were
performed by Dr. P. Snow at the Beckman Institute Protein Expression Facility at the California
Institute of Technology.2 HeLa cell nuclear extracts were kindly prepared in H.-C. Tai according
to published procedures.3 Y289L and wild-type GalT were expressed and purified as described
previously.4 All protein concentrations were measured using the Bradford assay (Bio-Rad
Laboratories, Hercules, CA).
General Reagents:
Unless otherwise noted, reagents were purchased from the commercial suppliers Fisher
(Fairlawn, NJ) and Sigma-Aldrich (St. Louis, MO) and were used without further purification.
Protease inhibitors were purchased from Sigma-Aldrich or Alexis Biochemicals (San Diego,
CA).  Bovine GalT, ovalbumin, and α-crystallin were obtained from Sigma-Aldrich.  Uridine
diphospho-D-[6-3H]galactose, Hyperfilm ECL and Amplify reagent were purchased from
Amersham Biosciences (Piscataway, NJ). WGA lectin was purchased from E-Y Laboratories
(San Mateo, CA). RL-2 antibody was purchased from Affinity Bioreagents (Golden, CO).
Alkaline phosphatase was purchased from New England Biolabs (Beverly, MA), and bovine
serum albumin (BSA) was obtained from Fisher. SuperSignal West Pico chemiluminescence
reagents and secondary antibodies were from Pierce (Rockford, IL), and the CTD110.6 antibody
was from Covance Research Products (Berkeley, CA). Nitrocellulose was from Schleicher and
Schuell (Keene, NH), and PVDF was from Millipore (Bedford, MA).
2-Acetonyl-2-deoxy-3,4,5-tri-O-acetyl-β-D-galactopyranose5
Ketone 2 (289 mg, 0.744 mmol) was dissolved in acetonitrile (1.5 mL), and Me2NH in THF (2.0
M solution, 2.80 mL, 5.60 mmol) was added.  The reaction mixture was stirred for 24 h at r.t.
S2
The solvents and reagents were evaporated in vacuo.  Flash chromatography on silica gel (1:1
hexanes: EtOAc) gave the monodeacetylated product (136 mg, 0.393 mmol, 53%) as a colorless
oil.
1H NMR (300 MHz, CDCl3): δ 5.49-5.46 (m, 1H, 1-H), 5.34-5.33 (m, 1H, 4-H), 5.10 (dd, J =
12.0, 3.0 Hz, 1H, 3-H), 4.39 (t, J = 6.6 Hz, 1H, 5-H), 4.18-4.04 (m, 2H, 6-H2), 2.84-2.72 (m, 1H,
2-H), 2.62-2.54 (m, 2H, 1’-H2), 2.17, 2.14, 2.06, 2.01 (4 x s, 12H, 3 x Ac, 3’-H3).
13C NMR (75 MHz, CDCl3): δ 207.1, 170.4, 170.3, 170.2, 92.8, 68.7, 66.7, 66.1, 62.3, 40.9, 34.7,
30.4, 20.7, 20.7, 20.7.
HRMS(FAB) calcd. for C15H23O9 [M+H]+ 347.1342, found 347.1342.
Dibenzyl (2-acetonyl-2-deoxy-3,4,5-tri-O-acetyl-α-D-galactopyranosyl) phophate (3) 6
The deprotected ketone (90 mg, 0.26 mmol) and 1H-tetrazole (91 mg, 1.3 mmol) were dissolved
in dichloromethane (3 mL).  The reaction mixture was cooled to -30 °C and dibenzyl N,N’-
diisopropylphosphamidite (170 µL, 0.52 mmol) was added.  The reaction mixture was warmed
to r.t. over 30 min and stirred at r.t.  After 1 h, the reaction mixture was again cooled to - 30 °C,
and mCPBA (229 mg, 1.30 mmol) was added.  The mixture was then stirred at 0 °C for 1 h and
at r.t. for 1 h.  The reaction was subsequently diluted in dichloromethane, washed twice with
10% Na2SO3, once with NaHCO3, and once with H2O.  The organic phase was dried over
MgSO4, filtered and concentrated.  Flash chromatography on silica gel (1:1 hexanes:EtOAc)
gave 3 (83 mg, 0.14 mmol, 54%) as a colorless oil.
1H NMR (300 MHz, CDCl3): δ 7.34-7.32 (m, 10H, arom), 5.86 (dd, J = 6.0, 3.3 Hz, 1H, 1-H),
5.29 (m, 1H, 4-H), 5.15-4.98 (m, 4H, bn), 4.92 (dd, J = 2.7, 12.0 Hz, 1H, 3-H), 4.25 (t, J = 6.5
Hz, 1H, 5-H), 4.07-3.93 (m, 2H, 6-H2), 2.90-2.80 (m, 1H, 2-H), 2.35 (d, J = 7.2 Hz, 2H, 1’-H2),
2.09, 1.95, 1.91, 1.87 (4 x s, 12H, 3 x ac, 3’-H2).
31P NMR (121 MHz, CDCl3): δ -1.31.
13C NMR (75 MHz, CDCl3): δ 205.7, 170.0, 170.0, 169.8, 128.6, 128.5, 128.5, 127.9, 97.7(d),
69.6(d), 69.5, 68.3, 68.0, 65.9, 61.7, 39.7, 34.4(d), 29.9, 20.6, 20.6, 20.5.
HRMS(FAB): calcd. for C29H36O12P [M+H]+ 607.1945, found 607.1924.
Uridine 5’-diphospho-2-acetonyl-2deoxy-α-D-galactopyranose diammonium salt (1) 7
A solution of dibenzyl phosphate 3 (80 mg, 0.13 mmol) and tri-n-octylamine (35 µL) in
methanol (10 mL) was hydrogenolyzed in the presence of 10% Pd/C (100 mg) under 1 atm H2
for 20 h.  The mixture was filtered, concentrated, dried and directly used in the next step.
UMP-morpholidate 4-morpholine-N,N’-dicyclohexylcarboxamidine salt (36 mg, 0.198 mmol)
was added and the mixture was evaporated three times from anhydrous pyridine (1.5 mL).  The
mixture was dissolved in pyridine (1.0 mL), 1H-tetrazole (28 mg, 0.40 mmol) was added, and the
solution was stirred for three days at r.t.  After evaporation of the solvent, the reaction product
was dissolved in a mixture of MeOH/water/TEA (2 mL/0.8 mL/0.4 mL) and stirred for 24 h.
The residue was then dissolved in water and dichloromethane, and the organic phase was
extracted twice with water.  The aqueous phases were combined and lyophilized.  The residue
was purified on a Bio-Gel P2 (extra fine) column (1.5 x 80 cm), and eluted with 0.1 M NH4HCO3
at a flow rate of 0.6 mL/min.  Lyophilization of the desired fractions (determined by HPLC,
Varian Microsorb C18, 100 mM NH4HCO3, 4.1 min) gave 1 (38.7 mg, 0.060 mmol, 45%) as a
colorless powder.
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1H NMR (300 MHz, D2O): δ 7.96 (d, J = 8.1 Hz, 1H, 6’’-H), 5.97-5.94 (m, 2H, 5’’-H, 1’-H),
5.55 (dd, J = 7.8, 3.3 Hz, 1H, 1-H ), 4.36-4.33 (m, 2H, 2’-H, 3’-H), 4.26-4.24 (m, 1H, 4’-H),
4.21-4.17 (m, 2H, 5’-H2), 4.13 (t, J = 5.1 Hz, 1H, 5-H), 3.88 (m, 1H, 4-H), 3.79-3.69 (m, 3H, 3-
H, 6-H2), 2.79-2.75 (m, J = 4.2 Hz, 2H, 1’’’-H2), 2.53 (m, 1H, 2-H), 2.24 (s, 3H, 3’’’-H3).
31P NMR (121 MHz, CDCl3): δ -10.74 (d, J = 19.5 Hz), -12.06 (d, J = 20.1 Hz).
13C NMR (75 MHz, D2O): δ 214.3, 166.3, 151.9, 141.8, 102.9, 96.5, 88.6, 83.6, 74.0, 72.1, 69.9,
68.2, 65.1, 63.9, 61.6, 43.5, 41.6, 30.3.
HRMS(EI) calcd. for C18H27O17N2P2  [M-H]- 605.0785, found 605.0803.
Labeling of the O-GlcNAc Peptide. The peptide TAPTS(O-GlcNAc)TIAPG (10µM) was
dissolved in 25 mM MOPS buffer, pH 6.7 containing 5 mM MnCl2 and 8 µM reference peptide
(ThermoFinnigan, San Jose, CA).  Ketone analogue 1 and mutant Y289L GalT were added to
final concentrations of 1 mM and 100 ng/µL, respectively.  Prior to enzyme addition, an aliquot
of the reaction was removed as an initial time point for LC-MS analysis.  Reactions were
incubated at 4 °C for 6 h, after which an aliquot of the reaction mixture was removed for product
analysis by LC-MS.  The remainder of the reaction was diluted 5-fold into PBS (final
concentration: 10.1 mM Na2HPO4, 1.76 mM KH2HPO4,, 137 mM NaCl, 2.7 mM KCl, pH 6.7),
and N-(aminooxyacetyl)-N’-(D-biotinoyl) hydrazine (Molecular Probes, Eugene, OR) was added
to a final concentration of 12 mM.  After 8 h at 25 °C, the extent of biotin-oxime product was
measured by LC-MS.  Optimization of the experimental parameters suggested that a 6000:1
molar ratio of aminooxy biotin was optimal for complete conversion to the oxime product.  Note
that different batches of aminooxy biotin were found to contain variable amounts of TFA salts,
affecting the final pH of the biotinylation reaction.  Labeling reactions with wild-type GalT were
performed identically, with the exception that reactions were incubated at 37 °C for 12 h.
LC-MS monitoring of O-GlcNAc peptide labeling reactions.  Liquid chromatography and
mass spectrometry (LC-MS) were performed on an LCQ Classic ion trap mass spectrometer
(ThermoFinnigan, San Jose, CA) interfaced with a Surveyor HPLC system (ThermoFinnigan,
San Jose, CA).  Approximately 10 pmoles of peptide from each labeling reaction was loaded
onto a Luna column (2mm i.d. X 50mm) prepacked with 3µm  100Å C18 RP particles.  Flow
rate was maintained at 190 µL/min with a gradient optimized for separation of the O-GlcNAc
peptide from labeled products.  LC buffer A consisted of 2% CH3CN in 0.1M aqueous AcOH
and buffer B consisted of 90% CH3CN in 0.1M aqueous AcOH.  The gradient consisted of 0-3
min, 2% B; 3-6 min, 2-11%B; 11-14.5 min 11-27.5% B, 14.5-18min 27.5-100% B; 18-22min
100% B where the initial 5 minutes of flow were diverted to waste in order to avoid
contamination of the mass spectrometer with salts.  The LCQ was operated in automated mode
using XcaliburTM software.  The electrospray voltage was 4.5 kV and the heated capillary was
200 °C.  Ion injection time was set at 200 ms for full MS scan mode of operation (3 microscans
per scan).  The ion selection window was set at 500-1700 m/z for all experiments.
Supplementary Figure 1 shows the progress of the ketone labeling reaction using Y289L
GalT and the subsequent reaction with aminooxy biotin, as monitored by LC-MS.  Base peak
chromatograms are shown before and 6 h after the addition of ketone analogue 1 and Y289L
GalT.  Complete conversion of the peptide to the desired ketone-labeled product was observed.
For the aminooxy biotin reaction, formation of the oxime product was monitored using an
extracted ion chromatogram within the mass range 1319.0-1321.0 m/z and 1633.0-1635.5 m/z,
which was generated post-acquisition via the XcaliburTM software.  Extracted ion chromatograms
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were necessary because the excess biotin in the reaction mixture dominated the base peak
chromatograms. No appreciable amounts of the unbiotinylated starting material were observed
after 8 h.  Mass spectrometric analysis confirmed the identity of each product (Supplementary
Figure 2).
Supplementary Figure 3 shows the progress of the labeling reaction using wild-type GalT
after 12 h at 37 °C.  The extent of conversion to ketone-labeled peptide was analyzed by
measuring peak areas for the starting material (peak a) and product (peak b) using XcaliburTM
software, under the assumption that the O-GlcNAc peptide and its ketone-labeled analogue had
similar ionization potentials.  Approximately 1.5% of the desired product was formed with the
wild-type GalT.
Labeling of CREB protein.  Recombinant O-GlcNAc glycosylated CREB was generated by
coexpression of CREB with O-GlcNAc glycosyltransferase in Sf9 cells as described previously.2
500 ng of CREB in 20 mM HEPES pH 7.9, 100 mM KCl, 0.2 mM EDTA, 15% glycerol was
added to 50 mM MOPS pH 6.45 containing 5 mM MnCl2 and 0.25 mU/µL alkaline
phosphatase.8  Analogue 1 and Y289L GalT were then added to final concentrations of 1 mM
and 40 ng/µL, respectively.  Control reactions without enzyme or analogue 1 were treated
identically.  Following incubation at 12 h at 4 °C, the reactions were diluted 5-fold into PBS
containing protease inhibitors (5 µg/mL pepstatin, 5 µg/mL chymostatin, 20 µg/mL leupeptin, 20
µg/mL aprotinin, 20 µg/mL antipain, 0.2 mM PMSF).  Aminooxy biotin was added to a final
concentration of 2 mM, and the biotinylation reactions were incubated with gentle shaking for 12
h at 37 °C.  Reactions were aliquoted for analysis and stopped by boiling in SDS-PAGE loading
dye.  Proteins were resolved by 10% SDS-PAGE, electrophoretically transferred to
nitrocellulose, and probed with streptavidin-HRP.
Nitrocellulose blots were blocked for 1 h at RT using 3% periodated-BSA9 in PBS, rinsed
once with TBS (50 mM Tris•HCl, 150 mM NaCl, pH 7.4) containing 0.05% (v/v) tween-20, and
probed with streptavidin-HRP (1:2500 to 1:5000) in TBS-0.05% tween for 1 h at RT.  Note that
we found some variability among different batches of streptavidin.  In some cases, blots were
probed for 1 h with streptavidin-HRP, rinsed several times with TBS-0.05% tween, and reprobed
with another aliquot of streptavidin-HRP.  After probing with streptavidin, membranes were
rinsed and washed 5X10 min with TBS-0.1% tween containing 0.05% BSA.  Streptavidin-HRP
signal was visualized by chemiluminescence upon exposure to film.  After streptavidin
visualization, membranes were stripped in 5 mM Na2HPO4 pH 7.5, 2% SDS, and 2 mM βME,
for 45 min at 60 °C, rinsed several times with dH20, and re-probed with α-CREB antibody as
previously described2 with the modification that the antibody was used at a concentration of
1:400.
Labeling reactions with CREB expressed in E. coli were performed identically.  To
generate the bacterial protein, rat CREB cDNA was cloned into the prokaryotic expression
vector pET23b(+) (Novagen, Madison, WI) using HindIII and NdeI restriction endonucleases.
Electrocompetent BL21(DE3) cells were electroporated and grown in Luria-Bertani media
supplemented with 100 mg/L ampicillin.  Protein expression was induced with 0.3 mM
isopropyl-β-D-thiogalactopyranoside.  Recombinant CREB was purified using Ni-NTA agarose
(Qiagen, Valencia, CA) as described previously.2
As demonstrated in Supplementary Figure 4, strong, selective labeling of glycosylated
CREB was observed upon treatment with both Y289L GalT and analogue 1.  With larger
quantities of protein, a faint background signal was observed, which was presumably due to the
S5
non-specific interaction of aminooxy biotin with the protein.  Importantly, the background signal
was readily diagnosed using control reactions in the absence of enzyme or analogue 1.  In the
case of E. coli CREB, for example, a weak background signal was observed over time, but no
selective enhancement of signal was seen in the presence of both enzyme and 1, indicating that
bacterially expressed CREB was not GlcNAc glycosylated.
Labeling of α-crystallin.  Bovine lens α-crystallin (a mixture of A and B chains) was resolved
by SDS-PAGE electrophoresis and Coomassie-stained with standards in order to quantify the
amount of A chain in the mixture.  For reactions, 8.7 µg of α-crystallin (6.5 µg of A chain) in 20
mM HEPES pH 7.9 was added to 50 mM MOPS pH 6.45 containing 5 mM MnCl2 and 0.25
mU/µL alkaline phosphatase.  Analogue 1 and Y289L GalT were added to final concentrations
of 1 mM and 100 ng/µL, respectively.  Reactions were incubated at 4 °C for 18 h and then
diluted 5-fold with PBS pH 6.7, protease inhibitors, and aminooxy biotin (6.5 mM final
concentration).  Biotinylation reactions were incubated with gentle shaking at 25 °C for 12 h.
The molar ratio of biotin to α-crystallin was adjusted to minimize background signal, while
maintaining reactivity over a reasonable time period.  We found that a 4000:1 molar ratio worked
successfully for these purposes.  After biotinylation, reactions were aliquoted for analysis and
subsequently boiled in SDS-PAGE loading dye.  Proteins were resolved by 15% SDS-PAGE,
transferred to nitrocellulose, and probed with streptavidin-HRP or stained with Coomassie
Brilliant Blue (Supplementary Figure 5).  Blotting with streptavidin-HRP was performed as
described above and produced a strong signal within 30 min.  In contrast, tritium labeling
required 8 days to obtain a moderate signal.  The difference in time corresponds to ~380-fold
improvement in detection sensitivity.
UDP-[3H]galactose labeling of α-crystallin. 3H-labeling was performed essentially as
described.10,11  Briefly, 8.7 µg of α-crystallin (6.5 µg of A chain) in 20 mM HEPES pH 7.9 was
added to 10 mM HEPES pH 7.9 containing 5 mM MnCl2 and protease inhibitors.  UDP-[3H]-
galactose was added to a final concentration of 0.03 µCi/µL, and the reaction was initiated with
the addition of 25 mU autogalactosylated bovine β1,4-galactosyltransferase.11  Reactions were
incubated at 37 °C for 1 h 15 min.  Reactions were subsequently aliquoted for analysis and
stopped by boiling with SDS-PAGE loading dye. Proteins were resolved by 15% SDS-PAGE,
stained with Coomassie Brilliant Blue, incubated with Amplify reagent, and dried for subsequent
exposure to Hyperfilm MP at –80 °C.
Western blotting of α-crystallin using antibodies RL-2 and CTD110.6.  α-Crystallin, and
appropriate positive and negative controls were resolved by 15% SDS-PAGE.  All Western
blotting steps were performed at RT unless otherwise noted.  Western blotting with the RL-2
antibody was performed according to reported methods12 with minor changes suggested by the
manufacturer to reduce background noise.  α -Crystallin and controls were electrophoretically
transferred to nitrocellulose blots, and the blots were blocked for 1 h in 5% BSA in high salt (250
mM) TBS-1% tween-20 (hsTBS-T).  RL-2 antibody, at a concentration of 1:2000, was
subsequently added in blocking buffer and blots were incubated for 1.5-2 h.  Blots were then
rinsed with hsTBST and washed 6X5 min.  Secondary goat anti-mouse IgG antibody was applied
at a concentration of 1:10,000 in hsTBS-T containing 1% BSA.  After 1 h, blots were rinsed and
washed as described before chemiluminescence detection on film (Supplementary Figure 6A).
Western blotting with the CTD110.6 antibody was performed according to manufacturer’s
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recommendations.  Briefly, α-crystallin and controls were transferred to PVDF and washed 2X
15 min with TBS-0.1% tween-20 (TBST). Blots were blocked in TBST containing 3% BSA for
1 h, rinsed 2X with TBST, and probed with CTD110.6 (1:2500) in blocking buffer for 1 h.  Blots
were then rinsed 2X with TBST and washed 2X5 min.  Secondary goat anti-mouse IgM antibody
was applied at a concentration of 1:10,000 in blocking buffer for 1 h, and blots were
subsequently rinsed with TBST and washed 5X5 min before chemiluminescence detection on
film (Supplementary Figure 6B).
WGA lectin blotting of α-crystallin.  WGA western blotting was performed essentially as
described.11,13  Briefly, α-crystallin and controls were resolved by 15% SDS-PAGE and
electrophoretically transferred to nitrocellulose.  Blots were blocked for 1 h in 3% periodate-
treated BSA in PBS, rinsed 2X15 min with PBS-0.05% tween-20 (PBST), and probed for 2 h
with WGA-HRP (1:8000 in PBST).  Subsequently, blots were rinsed with PBST, washed 3X10
min, then 3X20 min before chemiluminescence detection on film (Supplementary Figure 7).
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Supplementary Figure 1. Reverse phase LC-MS analysis of O-GlcNAc peptide labeling
reactions at (A) time 0, (B) 6 h after the addition of 1 and Y289L GalT, (C) 8 h after aminooxy
biotin addition.  Trace D shows aminooxy biotin in the absence of 1, Y289L GalT and O-
GlcNAc peptide.  A and B represent base peaks chromatograms, and C and D represent the
extracted ion chromatograms within the mass range 1319.0-1321.0 m/z and 1633.0-1635.5 m/z.
As shown in Supplementary Figure 2, peaks c1 and d represent the same biotin impurity.  The
slight difference in their retention times is due to minor differences in column equilibration time.
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Supplementary Figure 2.  Electrospray ionization mass spectra of the peaks in Supplementary
Figure 1. (A) Spectrum of the peptide starting material (peak a), [MGlcNAc+H]+ =1118.4.  The
fragment ion at 915.2 m/z represents the deglycosylated peptide [M+H]+, which was induced
during ionization in the mass spectrometer. (B) Spectrum of the ketone product (peak b), [Mketone-
GlcNAc+H]+ =1320.5.  Ions at 1118.4, 915.2, and 661.1 m/z represent the O-GlcNAc glycosylated
peptide, the deglycosylated peptide and the doubly charged species of the ketone labeled peptide,
respectively. (C) Spectra of the biotin impurity (peak c1), peak c2, and the oxime product (peak
c3)
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Supplementary Figure 2.  (continued)  The identity of the product was confirmed by ions 1633.6
and 817.7 m/z, which represent the singly and doubly charged species of the O-alkyl oxime
product, respectively.  The additional fragment ions at 1118.4 and 915.2 m/z correspond to the
O-GlcNAc glycosylated and deglycosylated peptide, respectively.  (D) Spectrum of the biotin
impurity (peak d), obtained by incubating biotin in the absence of 1, Y289L GalT and O-GlcNAc
peptide.  Note that the spectrum matches that of c1, indicating that these peaks arise from
aminooxy biotin.
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Supplementary Figure 3.  (A) Reverse phase LC-MS analysis and accompanying mass spectra
of the labeling reaction 12 h after the addition of 1 and wild-type GalT.  Both the starting
material (a) and ketone labeled peptide product peak (b) are visible in the base peak
chromatogram.  The latter peak intensity has been amplified 5-fold for clarity.  (B) The EI mass
spectra of peaks a and b confirm the identities of the O-GlcNAc glycosylated peptide,
[MGlcNAc+H]+ = 1118 m/z, and the product, [Mketone-GlcNAc+H]+ =1320.635 m/z and [Mketone-
GlcNAc+2H] 2+ = 661 m/z, respectively.
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Supplementary Figure 4. Labeling of glycosylated CREB from Sf9 cells (lanes 1-3 and 7-9) or
E.coli (lanes 4-6 and 10-12).  Strong streptavidin-HRP signal is observed upon treatment with
Y289L GalT and analogue 1 (lanes 1 and 7) relative to reactions lacking enzyme or 1 (lanes 2-3
and 8-9).  In contrast, no selective enhancement of the signal is observed for the negative control,
unglycosylated CREB from E.coli.
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Supplementary Figure 5. Streptavidin-HRP blot of the α-crystallin labeling reactions and the
accompanying Coomassie-stained gel of each reaction.  Selective labeling of α-crystallin A
chain was observed.  In contrast, no appreciable labeling was observed in the control reactions
lacking 1 or Y289L.  Coomassie gel bands of similar intensity confirm the presence of
comparable amounts of α-crystallin A chain.  Faint labeling of the B chain was observed,
consistent with reports that it is O-GlcNAc glycosylated.10
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Supplementary Figure 6.  Western blots of α-crystallin using the RL-2 antibody (A) and
CTD110.6 antibody (B).  Both antibodies effectively detected the O-GlcNAc present on the
CREB positive control and HeLa nuclear lysates, while the negative control, unglycosylated
CREB from E. coli, remained undetected.  However, the antibodies failed to appreciably detect
the O-GlcNAc present on α-crystallin, even when 10 µg of protein was used.  The arrow marks
the anticipated position of α-crystallin in the gel.
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Supplementary Figure 7.  Blotting of α-crystallin using WGA lectin.  While WGA detected the
N-linked terminal GlcNAc groups of the ovalbumin positive control, it could not detect the O-
GlcNAc moiety on α-crystallin.
